We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

45 hedge funds and large institutions have $34.1M invested in Cumberland Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more capital invested

Capital invested by funds: $29.4M → $34.1M (+$4.71M)

0% more funds holding

Funds holding: 45 → 45 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

55% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 20

Holders
45
Holders Change
–
Holders Change %
0%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
9
Reduced
20
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
+$3.81M
2
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
+$1.46M
3
GHA
GW Henssler & Associates
Georgia
+$1.01M
4
Norges Bank
Norges Bank
Norway
+$109K
5
Two Sigma Investments
Two Sigma Investments
New York
+$71.2K

Top Sellers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
-$2.36M
2
UCFA
United Capital Financial Advisors
Texas
-$1.09M
3
BG
BlackRock Group
United Kingdom
-$601K
4
Morgan Stanley
Morgan Stanley
New York
-$300K
5
Goldman Sachs
Goldman Sachs
New York
-$268K
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
$114K +$109K +22,400 New
SIM
27
Spark Investment Management
New York
$108K +$4.88K +1,000 +5%
MC
28
Menta Capital
California
$85K -$120K -24,500 -60%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$83K -$6.47K -1,325 -8%
Deutsche Bank
30
Deutsche Bank
Germany
$81K -$693 -142 -0.9%
State Street
31
State Street
Massachusetts
$75K -$22.9K -4,700 -24%
DAM
32
Delta Asset Management
Tennessee
$56K – – –
PPA
33
Parametric Portfolio Associates
Washington
$52K +$49.6K +10,161 New
WA
34
WealthTrust-Arizona
Arizona
$38K -$6K -1,230 -14%
CCMH
35
Cornerstone Capital Management Holdings
New York
$30K – – –
U
36
UBS
Switzerland
$22K -$727 -149 -3%
BA
37
BlackRock Advisors
Delaware
$21K -$242K -49,486 -92%
NFA
38
Nationwide Fund Advisors
Ohio
$20K – – –
Citigroup
39
Citigroup
New York
$19K -$3.83K -785 -17%
OC
40
Oakworth Capital
Alabama
$16K +$14.9K +3,052 New
PNC Financial Services Group
41
PNC Financial Services Group
Pennsylvania
$8K -$11.3K -2,323 -59%
HF
42
Hoxton Financial
West Virginia
$2K +$547 +112 +42%
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$337 +$322 +66 New
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3 – – –
BG
45
BlackRock Group
United Kingdom
– -$601K -132,563 Closed
Goldman Sachs
46
Goldman Sachs
New York
– -$268K -59,071 Closed
BAM
47
Berkshire Asset Management
Pennsylvania
– -$127K -28,100 Closed
Nomura Holdings
48
Nomura Holdings
Japan
– -$48K -10,500 Closed
TRCT
49
Tower Research Capital (TRC)
New York
– -$8K -1,688 Closed
Bank of America
50
Bank of America
North Carolina
– -$4.3K -880 -98%
1
2
3

CPIX Hedge Fund Activity: Q4 2013 in Review

45 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2013, worth a combined $34.1M — up 16% from $29.4M a quarter earlier.

Fund positioning in CPIX was balanced in Q4 2013: 6 funds opened new positions, 6 closed out, 9 added to existing stakes and 20 trimmed.

The largest buyer was Ariel Investments, adding an estimated $3.81M. The largest seller was BlackRock Institutional Trust, cutting an estimated $2.36M.

  • 45 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $34.1M of Cumberland Pharmaceuticals stock for Q4 2013, up 16% quarter-over-quarter.
  • 6 funds opened new Cumberland Pharmaceuticals positions in Q4 2013 and 6 closed out, a net change of 0 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q4 2013 was Ariel Investments, an estimated $3.81M added.
  • The largest Cumberland Pharmaceuticals seller in Q4 2013 was BlackRock Institutional Trust, an estimated $2.36M sold.

Based on aggregated 13F filings for Q4 2013.